[ Price : $8.95]
FDA makes available a draft guidance entitled Clostridioides difficile Infection (CDI): Developing Drugs for Treatment, Reduction ...[ Price : $8.95]
AstraZeneca reports positive results from two trials evaluating new breast cancer treatments.[ Price : $8.95]
Federal Register notice: FDA launches a Rare Disease Endpoint Advancement Pilot Meeting Program.[ Price : $8.95]
FDA posts eight generic drug research priority initiatives for FY 2023.[ Price : $8.95]
FDA says Baxter International has issued an urgent medical device correction for its WatchCare incontinence system that may cause ...[ Price : $8.95]
FDA publishes a guidance to help agency staff request additional information needed to make decisions on medical device marketing ...[ Price : $8.95]
The Medical Device Innovation Consortium releases its first medical device manufacturer benchmark report on cybersecurity maturity...[ Price : $8.95]
FDA commissioner Robert Califf says he hopes Congress will include regulation of laboratory-developed tests and several other issu...